Answers are grounded in this paper and cite their sources.
With the development of new techniques and procedures to treat infertility, the perceptions and concerns of the public have also evolved.Initially, assisted reproduction technologies (ART) were primarily associated with insemination of enhanced husband or donor sperm, and the public's general attitude was one of concern for the privacy of the patients.With increases of invasiveness and ethical complexity in techniques such as in vitro fertilization (IVF), intracytoplasmic injection, and preimplantation genetic diagnosis and with the unfortunate and highly publicized mismanagement or unethical actions of some ART programs, the public's attitude has evolved more to concern for the protection of patients, which has fueled calls for oversight of the industry and spurred the government to proceed in setting regulations.Assisted reproduction laboratories now stand at an intersection in the process of federal regulation.The Clinical Laboratory Improvement Act of 1988 (CLIA 88) has caused significant operating changes for many assisted reproduction laboratories, including the initiation of proficiency testing (PT) and quality improvement programs.However, for many laboratories, the changes have been made solely or primarily to pass an accreditation inspection, rather than as an actual impetus to laboratory improvement.Other laboratories, including physician office laboratories (POLs), have continued to operate without regard to the requirements of CLIA 88, with no apparent repercussions.These 2 factors have increased cynicism and have led many lab directors to consider laboratory regulation not only burdensome and ineffective, but also
No takes yet. Share an insight, caveat, or question.
Carrell et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: